Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.
Monday August 9 2021BTIG Virtual Biotechnology Conference
September 13th – September 15th, 2021H.C. Wainwright 23rd Annual Global Investor Conference
September 27-30, 2021Cantor Fitzgerald Virtual Global Healthcare Conference
- Conference Dates: September 20th-23rd - BETHESDA, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit and...
BETHESDA, Md., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Manolo Bellotto, Ph.D., General Manager and President at Gain, will present an overview on the Company’s proprietary Structurally Targeted Allosteric Regulators (STARs) for GM1...
GT-02287and GT-02329 compounds display positive effects on GCase activityand related parameters--- Study results demonstrate an increase in GCase protein levels with transport to the lysosomes and decrease of glucosylceramide andα-synuclein-p129 levels--- Comprehensive study results to be presented at Michael J. Fox Foundation’s upcomingInnovating from Drug Discovery to the Clinic: Novel Approaches to PD Therapeutic Development webinar--- IND-initiating study planned for Q4’21 BETHESDA,...
GAIN THERAPEUTICS INC.
4800 Hampden Ln, St 200
Bethesda, MD 20814,
Phone: +1 301 500 1556
LifeSci Advisors, LLC
1 International Place
Boston, MA 02110
Phone: +1 617-430-7576